Reviva Pharmaceuticals Holdings (RVPH) Tax Rate (2021 - 2026)
Reviva Pharmaceuticals Holdings' (RVPH) quarterly Tax Rate came in at 0.11% in Q2 2026, up 2.0% year-over-year from 0.11% in Q2 2025, and down 2.71% quarter-over-quarter from 0.1% in Q1 2026.
Analysis
Reviva Pharmaceuticals Holdings (RVPH) Tax Rate (2021 - 2026) Analysis & Trends
Reviva Pharmaceuticals Holdings has disclosed Tax Rate across 6 years of filings, most recently posting 0.11% for Q2 2026.
- In Q2 2026, Tax Rate rose 2.0% year-over-year to 0.11%; the TTM figure through Jun 2026 stood at 31.87% (up 869.0% YoY), while the FY2025 annual figure was 20.91%, down 9.0% from the prior year.
- Tax Rate came in at 0.11% for Q2 2026 at Reviva Pharmaceuticals Holdings, down from 0.1% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 121.16% in Q4 2025 to a low of 0.13% in Q2 2025.
- Average Tax Rate over 5 years is 21.02%, with a median of 0.07% recorded in 2025.
- Year-over-year, Tax Rate surged 3832 bps in 2023 and slipped 6 bps in 2024.
- Over 5 years, Tax Rate stood at 49.19% in 2022, then soared by 78 bps to 87.51% in 2023, then advanced by 15 bps to 100.62% in 2024, then gained by 20 bps to 121.16% in 2025, then slumped by 100 bps to 0.11% in 2026.
- Per Business Quant data, the three most recent Tax Rate figures were 0.11% in Q2 2026, 0.1% in Q1 2026, and 121.16% in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 17.98% |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 15.47% |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | -95.75% |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | -23.71% |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | 62.33% |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | -31.96% |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 22.08% |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | 10.65% |
| 10 | Reviva Pharmaceuticals Holdings | 6.95 Mn | 6.95 Mn | - | -0.11% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.11% |
| Mar 31, 2026 | -0.10% |
| Dec 31, 2025 | 121.16% |
| Sep 30, 2025 | -0.07% |
| Jun 30, 2025 | -0.13% |
| Mar 31, 2025 | -0.08% |
| Dec 31, 2024 | 100.62% |
| Jun 30, 2024 | -0.09% |
| Mar 31, 2024 | -0.10% |
| Dec 31, 2023 | 87.51% |
| Sep 30, 2023 | -0.11% |
| Jun 30, 2023 | -0.06% |
| Mar 31, 2023 | -0.04% |
| Dec 31, 2022 | 49.19% |
| Sep 30, 2022 | -0.05% |
| Jun 30, 2022 | -0.13% |
| Mar 31, 2022 | -0.05% |
| Sep 30, 2021 | -0.09% |
| Jun 30, 2021 | -0.24% |
| Mar 31, 2021 | -0.08% |